Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings

6.89
+0.14002.07%
Volume:3K
Turnover:17.76K
Market Cap:44.86M
PE:-1.09
High:6.93
Open:6.55
Low:6.55
Close:6.75
52wk High:49.50
52wk Low:3.64
Shares:6.51M
Float Shares:3.74M
Volume Ratio:0.51
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3221
EPS(LYR):-8.0804
ROE:--
ROA:-297.37%
PB:-2.54
PE(LYR):-0.85

Loading ...

Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 24, 2025

Correspondence

Form CORRESP - Correspondence
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 01, 2024

Correspondence

Form CORRESP - Correspondence
Jul 31, 2024

Correspondence

Form CORRESP - Correspondence